发明名称 THERAPY OF MELANOMA
摘要 PROBLEM TO BE SOLVED: To treat patients having melanoma surgically removed with a higher patient compliance by administering a therapeutically effective amount of a PEG-modified interferon-αto the above patients for a sufficient period to increase a nonprogressive survival time. SOLUTION: This method for the therapy of melanoma is to administer a therapeutically effective amount of a PEG-modified interferon-α(preferably PEG-modified interferon-α-2a and/or PEG-modified interferon-α-2b) to patients having melanoma surgically removed (preferably untreated patients, especially untreated patients having melanoma newly diagnosed, or patients experienced in treatment, especially patients experienced in treatment and having intolerance or resistance to interferon-α) for a sufficient period (preferably at least about 24 months) to increase a non-proliferating survival time.
申请公布号 JP2000319195(A) 申请公布日期 2000.11.21
申请号 JP20000105524 申请日期 2000.04.06
申请人 SCHERING PLOUGH CORP 发明人 RYBAK MARY ELLEN;ROSE ESTHER HELEN
分类号 A61K38/21;A61K47/48;A61P17/00;A61P35/00;(IPC1-7):A61K38/21 主分类号 A61K38/21
代理机构 代理人
主权项
地址